Recent Yaz DVT Lawsuits Have Doctors Seeking Safer Treatment Using External Medical Devices
Tampa, FL (Law Firm Newswire) March 14, 2013 – Oral contraceptives manufactured by Bayer are being blamed for complications including deep vein thrombosis.
The drugs, called Yaz and Yasmin, became popular in the United States in 2006. Between 2004 and 2008, the FDA received reports of more than 50 deaths blamed on the drugs. Studies have shown a correlation between the drugs and higher rates of deep vein thrombosis (DVT), pulmonary embolism (PE) and blood clots.
Greg Grambor, President of Vascular PRN, a distributor of DVT prevention devices, commented, “Deep vein thrombosis is a serious condition that is often treated with prescription blood thinners, which can be expensive and have serious potential side effects themselves. Fortunately, the condition is very treatable using external medical devices.”
A lawsuit was recently filed against Bayer in California on behalf of 10 plaintiffs. It references a 2002 study published in the British Medical Journal connecting Yaz to DVT and PE.
“Vascular PRN offers a range of devices that prevent DVT by massaging the limbs using sequential compression,” Grambor continued. “This enhances blood flow and prevents clots.”
DVT and PE involve the formation of clots in the cardiovascular system. If these clots break free and enter vital organs, they can be life-threatening. A clot in the brain can cause a stroke, or a clot in the heart can cause a heart attack.
“A woman who wishes to continue taking Yaz but is concerned about side effects could, with a doctor's prescription, use a portable compression device like the PolyGel Ca5 unit as a precautionary measure. This device is user-friendly and lightweight and can be used while driving a car, watching TV, or sleeping,” Grambor added.
DVT and PE are seen most often in elderly, bedridden patients who must be moved and turned frequently by caregivers in order to prevent blood clots.
“Our DVT prevention devices are widely used in nursing homes and hospitals on bedridden patients. They are invaluable to treatment facilities in avoiding medical malpractice lawsuits because they are so effective at preventing dangerous blood clots,” Grambor said.
601 S. Falkenburg Road, Suite 1-4
Tampa, FL 33619
View Larger Map
- AMA Blasts Medicare Part B Drug Price Plan
Votes to ask CMS to withdraw proposal by Joyce Frieden News Editor, MedPage Today CHICAGO — A proposal by the Centers for Medicare & Medicaid Services (CMS) to change the way Medicare pays for drugs under the Part B program would hurt physician practices, the American Medical Association said at its annual meeting here. […]
- Low Level Laser Combine with Pneumatic Compression May Prove More Effective In Treatment Of Lymphedema
by Erkan Kozanoglu, et al, Faculty of Medicine, Cukurova University, Adana, Turkey Abstract Objective: To compare the long-term efficacy of pneumatic compression and low-level laser therapies in the management of postmastectomy lymphoedema. Design: Randomized controlled trial. Setting: Department of Physical Medicine and Rehabilitation of Cukurova University, Turkey. Subjects: Forty-seven patients with postmastectomy lymphoedema were enrolled in […]
- SEXUALITY AND DEMENTIA
Balancing resident rights and safety. Excerpted from an article by Lee Ann Griffen in the Florida Health Care Association’s newsletter “Pulse”. “Competent residents engaging in consensual sexual activity is not a cause for undue concern in assisted living, especially considering many residents have their own rooms which they call home. CMS’ interpretation of Home and […]